{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:30:27Z","timestamp":1787621427122,"version":"build-2736575974"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,1]]},"abstract":"<jats:p>Testotoxicosis, a form of gonadotropin-independent precocious puberty, results from an activating mutation of the luteinizing hormone receptor expressed in testicular Leydig cells. Affected males experience early testosterone secretion, virilization, advancing bone age, and resultant short stature. Recently, the use of combination therapy with a potent antiandrogen agent (bicalutamide) and a third-generation aromatase inhibitor (anastrozole or letrozole) was reported to yield encouraging short-term results. We present here the results of longer-term treatment (4.5 and 5 years) with this combination therapy in 2 boys who demonstrated that it is well tolerated, slows bone-age advancement in the face of continued linear growth, and prevents progression of virilization.<\/jats:p>","DOI":"10.1542\/peds.2010-0596","type":"journal-article","created":{"date-parts":[[2010,8,17]],"date-time":"2010-08-17T03:34:45Z","timestamp":1282016085000},"page":"e728-e733","source":"Crossref","is-referenced-by-count":49,"title":["Bicalutamide and Third-Generation Aromatase Inhibitors in Testotoxicosis"],"prefix":"10.1542","volume":"126","author":[{"given":"Anne M.","family":"Lenz","sequence":"first","affiliation":[{"name":"Department of Pediatric Endocrinology, Diabetes and Metabolism, All Children's Hospital and University of South Florida, St Petersburg, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Shulman","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Diabetes and Metabolism, All Children's Hospital and University of South Florida, St Petersburg, Florida;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica A.","family":"Eugster","sequence":"additional","affiliation":[{"name":"Section of Pediatric Endocrinology, James Whitcomb Riley Hospital for Children, Indiana University, Indianapolis, Indiana;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Rahhal","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Peyton Manning Children's Hospital at St Vincent, Indianapolis, Indiana; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Fuqua","sequence":"additional","affiliation":[{"name":"Section of Pediatric Endocrinology, James Whitcomb Riley Hospital for Children, Indiana University, Indianapolis, Indiana;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ora H.","family":"Pescovitz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Section of Pediatric Endocrinology, James Whitcomb Riley Hospital for Children, Indiana University, Indianapolis, Indiana;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2010,9,1]]},"reference":[{"issue":"6447","key":"2021121009445434300_B1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/365652a0","article-title":"A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty","volume":"365","author":"Shenker","year":"1993","journal-title":"Nature"},{"issue":"7","key":"2021121009445434300_B2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/jmg.32.7.553","article-title":"Identification of constitutively activating mutation of the luteinising hormone receptor in a family with male limited gonadotropin independent precocious puberty (testotoxicosis)","volume":"32","author":"Kawate","year":"1995","journal-title":"J Med Genet"},{"issue":"2","key":"2021121009445434300_B3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/jcem-52-2-271","article-title":"Testicular Leydig cell hyperplasia as a cause of familial sexual precocity","volume":"52","author":"Schedewie","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021121009445434300_B4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1210\/jcem-57-3-571","article-title":"Gonadotropin independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases","volume":"57","author":"Rosenthal","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2021121009445434300_B5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-3476(85)80460-1","article-title":"Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis","volume":"106","author":"Egli","year":"1985","journal-title":"J Pediatr"},{"issue":"8","key":"2021121009445434300_B6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM198408233110807","article-title":"Male-limited familial precocious puberty in three generations: apparent Leydig-cell autonomy and elevated glycoprotein hormone alpha subunit","volume":"311","author":"Reiter","year":"1984","journal-title":"N Engl J Med"},{"issue":"2","key":"2021121009445434300_B7","first-page":"77","article-title":"Testotoxicosis: current viewpoint","volume":"3","author":"Reiter","year":"2005","journal-title":"Pediatr Endocrinol Rev"},{"key":"2021121009445434300_B8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.mce.2005.11.048","article-title":"LH receptor gene mutations and polymorphisms: an overview","volume":"260","author":"Piersma","year":"2007","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"2021121009445434300_B9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1086\/302602","article-title":"Naturally occurring mutations of the luteinizing-hormone receptor: lessons learned about reproductive physiology and G protein-coupled receptors","volume":"65","author":"Latronico","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"6493","key":"2021121009445434300_B10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/371109a0","article-title":"Signal transduction: why testes are cool","volume":"371","author":"Clapham","year":"1994","journal-title":"Nature"},{"issue":"5","key":"2021121009445434300_B11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000185521","article-title":"Long-term outcome of male-limited gonadotropin-independent precocious puberty","volume":"48","author":"Bertelloni","year":"1997","journal-title":"Horm Res"},{"issue":"3","key":"2021121009445434300_B12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jpeds.2006.04.027","article-title":"Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole","volume":"149","author":"Kreher","year":"2006","journal-title":"J Pediatr"},{"issue":"5","key":"2021121009445434300_B13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1210\/jcem-63-5-1193","article-title":"Mechanism of inhibition of human testicular steroidogenesis by oral ketoconazole","volume":"63","author":"Rajfer","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"2021121009445434300_B14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM198504183121604","article-title":"Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy","volume":"312","author":"Holland","year":"1985","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121009445434300_B15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1210\/endo-97-1-52","article-title":"Antiandrogenic effect of spironolactones: mechanism of action","volume":"97","author":"Corvol","year":"1975","journal-title":"Endocrinology"},{"issue":"1","key":"2021121009445434300_B16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1210\/jc.2004-1438","article-title":"Adult height after ketoconazole treatment in patients with familial male-limited precocious puberty","volume":"90","author":"Soriano-Guill\u00e9n","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2021121009445434300_B17","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1651-2227.1994.tb13192.x","article-title":"Hazards of ketoconazole therapy in testotoxicosis","volume":"83","author":"Babovic-Vuksanovic","year":"1994","journal-title":"Acta Paediatr"},{"issue":"1","key":"2021121009445434300_B18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2265.2007.03160.x","article-title":"Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole","volume":"69","author":"Almeida","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3 Spec No.","key":"2021121009445434300_B19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/0002-9343(87)90123-9","article-title":"Persistent adrenal insufficiency secondary to low-dose ketoconazole therapy","volume":"82","author":"Best","year":"1987","journal-title":"Am J Med"},{"issue":"8","key":"2021121009445434300_B20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM198902233200805","article-title":"Treatment of familial male precocious puberty with spironolactone and testolactone","volume":"320","author":"Laue","year":"1989","journal-title":"N Engl J Med"},{"issue":"1","key":"2021121009445434300_B21","first-page":"151","article-title":"Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin","volume":"76","author":"Laue","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2021121009445434300_B22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jcem.84.1.5413","article-title":"Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset","volume":"84","author":"Leschek","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2021121009445434300_B23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000473846","article-title":"The development of Casodex (bicalutamide): preclinical studies","volume":"29","author":"Furr","year":"1996","journal-title":"Eur Urol"},{"issue":"12","key":"2021121009445434300_B24","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens","volume":"80","author":"Morishima","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2021121009445434300_B25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.mce.2006.04.031","article-title":"Use of aromatase inhibitors to increase final height","volume":"254\u2013255","author":"Dunkel","year":"2006","journal-title":"Mol Cell Endcrinol"},{"issue":"9","key":"2021121009445434300_B26","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1210\/jc.2004-0082","article-title":"Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double blind, placebo-controlled trial","volume":"89","author":"Plourde","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2021121009445434300_B27","doi-asserted-by":"crossref","first-page":"6396","DOI":"10.1210\/jc.2005-1392","article-title":"Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial","volume":"90","author":"Hero","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021121009445434300_B28","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jcem.85.3.6462","article-title":"Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia","volume":"85","author":"Merke","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2021121009445434300_B29","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1158\/1078-0432.CCR-04-2187","article-title":"Aromatase inhibition: translation into a successful therapeutic approach","volume":"11","author":"Geisler","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2021121009445434300_B30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1515\/JPEM.2008.21.10.995","article-title":"Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty","volume":"21","author":"Eyssette-Guerreau","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"2021121009445434300_B31","first-page":"2370","article-title":"Estrogen suppression in males: metabolic effects","volume":"85","author":"Mauras","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2021121009445434300_B32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000208803","article-title":"Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature","volume":"71","author":"Hero","year":"2009","journal-title":"Hormone Res"},{"issue":"9","key":"2021121009445434300_B33","first-page":"3027","article-title":"Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback","volume":"85","author":"Hayes","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021121009445434300_B34","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jc.2009-2108","article-title":"Estrogen negative feedback on gonadotropin secretion: evidence for a direct pituitary effect in women","volume":"95","author":"Shaw","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/126\/3\/e728\/846707\/zpe0091000e728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/126\/3\/e728\/846707\/zpe0091000e728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T21:44:16Z","timestamp":1639172656000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/126\/3\/e728\/66198\/Bicalutamide-and-Third-Generation-Aromatase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,1]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,9,1]]},"published-print":{"date-parts":[[2010,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-0596","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,1]]}}}